shashank5208 personal page - To The Moon

shashank5208

shashank5208

No personal profile

5Follow

3Followers

0Topic

0Badge

2021-08-09

$Moderna, Inc.(MRNA)$Yes yes yes

2021-08-09

Share price is more dependent forwarded earning based P/E and not current.

@夏禾木:$BioNTech SE(BNTX)$我覺得我沒有格局，留下了沒有格局的淚水……我知道炒股不能看市盈率，但真的太嚇人了……想買又不敢買[流淚] 下來點讓我上個車行不行……

2021-08-09

$BioNTech SE(BNTX)$Next target 500

2021-08-09

$Microvast Holdings, Inc.(MVST)$This is a hidden gem

2021-08-05

$BioNTech SE(BNTX)$More more more

2021-08-04

$BioNTech SE(BNTX)$To the moon target 1000

2021-06-26

$Virgin Galactic(SPCE)$Going to moon

2021-06-18

Thanks, noted

Sorry, the original content has been removed

2021-06-18

Good

China new energy vehicle sales to grow over 40%/yr in next 5 yrs -industry body

2021-06-17

This is an unique concept.. I am sure Apple will risewith this

Apple Struggles in Push to Make Healthcare Its Greatest Legacy

2021-06-17

Good

Cruise Stocks Gain As Wolfe Upgrades On Improving Demand

2021-06-17

Agree

Buy Coinbase on the dip for a long-term opportunity on the crypto economy, Canaccord says

2021-06-07

$BioNTech SE(BNTX)$Guys hold on to this gold..

2021-05-04

$BioNTech SE(BNTX)$this will go to 1000 $ soon

2021-04-28

$BioNTech SE(BNTX)$I consider Pfizer BionTech Vaccine as the best Covid 19 vaccine the world has...

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3572681899540620","uuid":"3572681899540620","gmtCreate":1609603883820,"gmtModify":1616761644139,"name":"shashank5208","pinyin":"shashank5208","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":5,"tweetSize":19,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.22","exceedPercentage":"93.01%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.14%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":6,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":898760230,"gmtCreate":1628522412820,"gmtModify":1703507584548,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572681899540620","authorIdStr":"3572681899540620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>Yes yes yes","listText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>Yes yes yes","text":"$Moderna, Inc.(MRNA)$Yes yes yes","images":[{"img":"https://static.tigerbbs.com/3b8a7274296476e2351a327a7d00daf9","width":"1284","height":"2223"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/898760230","isVote":1,"tweetType":1,"viewCount":310,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":898780954,"gmtCreate":1628521898678,"gmtModify":1703507568805,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572681899540620","authorIdStr":"3572681899540620"},"themes":[],"htmlText":"Share price is more dependent&nbsp;forwarded earning based P/E and not current.","listText":"Share price is more dependent&nbsp;forwarded earning based P/E and not current.","text":"Share price is more dependent forwarded earning based P/E and not current.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/898780954","repostId":"898714123","repostType":1,"repost":{"id":898714123,"gmtCreate":1628521757062,"gmtModify":1703507566677,"author":{"id":"333474855162240","authorId":"333474855162240","name":"夏禾木","avatar":"https://static.laohu8.com/41c2bd4f64df098421e74aab2f345a3b","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"333474855162240","authorIdStr":"333474855162240"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>我覺得我沒有格局，留下了沒有格局的淚水……我知道炒股不能看市盈率，但真的太嚇人了……想買又不敢買[流淚]&nbsp;下來點 讓我上個車行不行……","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>我覺得我沒有格局，留下了沒有格局的淚水……我知道炒股不能看市盈率，但真的太嚇人了……想買又不敢買[流淚]&nbsp;下來點 讓我上個車行不行……","text":"$BioNTech SE(BNTX)$我覺得我沒有格局，留下了沒有格局的淚水……我知道炒股不能看市盈率，但真的太嚇人了……想買又不敢買[流淚] 下來點 讓我上個車行不行……","images":[{"img":"https://static.tigerbbs.com/56a757c278c66ce146f219aef28916f1","width":"828","height":"1792"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/898714123","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":236,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898420587,"gmtCreate":1628518132149,"gmtModify":1703507454342,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572681899540620","authorIdStr":"3572681899540620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>Next target 500","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>Next target 500","text":"$BioNTech SE(BNTX)$Next target 500","images":[{"img":"https://static.tigerbbs.com/a045f2af6246ecbc78e64cab1f82193a","width":"1284","height":"2457"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/898420587","isVote":1,"tweetType":1,"viewCount":505,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":898229371,"gmtCreate":1628502320293,"gmtModify":1703507170415,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572681899540620","authorIdStr":"3572681899540620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MVST\">$Microvast Holdings, Inc.(MVST)$</a>This is a hidden gem","listText":"<a href=\"https://laohu8.com/S/MVST\">$Microvast Holdings, Inc.(MVST)$</a>This is a hidden gem","text":"$Microvast Holdings, Inc.(MVST)$This is a hidden gem","images":[{"img":"https://static.tigerbbs.com/a5522baaa5c715951a2f57095a2edf48","width":"1284","height":"2223"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/898229371","isVote":1,"tweetType":1,"viewCount":274,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":899996408,"gmtCreate":1628149537304,"gmtModify":1703502122376,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572681899540620","authorIdStr":"3572681899540620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>More more more","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>More more more","text":"$BioNTech SE(BNTX)$More more more","images":[{"img":"https://static.tigerbbs.com/abc428ee0703444be2d93452f8ac20e7","width":"1284","height":"2223"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/899996408","isVote":1,"tweetType":1,"viewCount":332,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":890181635,"gmtCreate":1628086861327,"gmtModify":1703501018125,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572681899540620","authorIdStr":"3572681899540620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>To the moon target 1000","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>To the moon target 1000","text":"$BioNTech SE(BNTX)$To the moon target 1000","images":[{"img":"https://static.tigerbbs.com/719384725b70893f7f10e49c0f12db2c","width":"1284","height":"2457"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/890181635","isVote":1,"tweetType":1,"viewCount":171,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":125596029,"gmtCreate":1624678974361,"gmtModify":1703843472809,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572681899540620","authorIdStr":"3572681899540620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SPCE\">$Virgin Galactic(SPCE)$</a>Going to moon","listText":"<a href=\"https://laohu8.com/S/SPCE\">$Virgin Galactic(SPCE)$</a>Going to moon","text":"$Virgin Galactic(SPCE)$Going to moon","images":[{"img":"https://static.tigerbbs.com/c3f985051b5ac72ac3116795e26adba4","width":"1284","height":"2223"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/125596029","isVote":1,"tweetType":1,"viewCount":203,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":166893327,"gmtCreate":1624000072569,"gmtModify":1703826189270,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572681899540620","authorIdStr":"3572681899540620"},"themes":[],"htmlText":"Thanks, noted","listText":"Thanks, noted","text":"Thanks, noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166893327","repostId":"2144742697","repostType":4,"isVote":1,"tweetType":1,"viewCount":248,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166890269,"gmtCreate":1624000000151,"gmtModify":1703826186988,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572681899540620","authorIdStr":"3572681899540620"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166890269","repostId":"1130200368","repostType":4,"repost":{"id":"1130200368","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623992866,"share":"https://ttm.financial/m/news/1130200368?lang=&edition=fundamental","pubTime":"2021-06-18 13:07","market":"hk","language":"en","title":"China new energy vehicle sales to grow over 40%/yr in next 5 yrs -industry body","url":"https://stock-news.laohu8.com/highlight/detail?id=1130200368","media":"Reuters","summary":"SHANGHAI, June 18  - China's new energy vehicle  sales are expected to grow more than 40% each year in the next five years, a senior official at the China Association of Automobile Manufacturers  said on Friday.Fu Bingfeng, executive vice chairman of CAAM, made the remarks at a conference held by the industry body in Shanghai.Fu's presentation showed that CAAM forecasts sales of NEVs, including battery electric, plug-in hybrid and hydrogen fuel cell vehicles, to hit 1.9 million units this year a","content":"<p>SHANGHAI, June 18 (Reuters) - China's new energy vehicle (NEV) sales are expected to grow more than 40% each year in the next five years, a senior official at the China Association of Automobile Manufacturers (CAAM) said on Friday.</p>\n<p>Fu Bingfeng, executive vice chairman of CAAM, made the remarks at a conference held by the industry body in Shanghai.</p>\n<p>Fu's presentation showed that CAAM forecasts sales of NEVs, including battery electric, plug-in hybrid and hydrogen fuel cell vehicles, to hit 1.9 million units this year and 2.7 million vehicles in 2022.</p>\n<p>NEV makers, such as Tesla Inc, Nio Inc, Xpeng Inc&nbsp;and BYD, are expanding manufacturing capacity in China, encouraged by the government's promotion of greener vehicles to cut pollution.</p>\n<p>China could extend tax exemptions on NEV purchases beyond 2022 to support development of the sector, Wan Gang, a high-ranking government industrial policy adviser who is often referred to in state media as China's \"father of EV\", said at the same CAAM conference.</p>\n<p>Shares in China's NEV-related companies climbed after the forecast.</p>\n<p>Top battery maker CATL(300750.SZ)&nbsp;gained 3.7%. Hunan Zhongke Electric Co Ltd(300035.SZ), Ningbo Rongbay New Energy Technology Co Ltd(688005.SS), Guangzhou Tinci Materials Technology Co Ltd(002709.SZ)and BYD climbed between 2.9% and 10%.</p>\n<p>Reporting by Yilei Sun and Tony Munroe; Editing by Muralikumar Anantharaman</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China new energy vehicle sales to grow over 40%/yr in next 5 yrs -industry body</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina new energy vehicle sales to grow over 40%/yr in next 5 yrs -industry body\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-18 13:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SHANGHAI, June 18 (Reuters) - China's new energy vehicle (NEV) sales are expected to grow more than 40% each year in the next five years, a senior official at the China Association of Automobile Manufacturers (CAAM) said on Friday.</p>\n<p>Fu Bingfeng, executive vice chairman of CAAM, made the remarks at a conference held by the industry body in Shanghai.</p>\n<p>Fu's presentation showed that CAAM forecasts sales of NEVs, including battery electric, plug-in hybrid and hydrogen fuel cell vehicles, to hit 1.9 million units this year and 2.7 million vehicles in 2022.</p>\n<p>NEV makers, such as Tesla Inc, Nio Inc, Xpeng Inc&nbsp;and BYD, are expanding manufacturing capacity in China, encouraged by the government's promotion of greener vehicles to cut pollution.</p>\n<p>China could extend tax exemptions on NEV purchases beyond 2022 to support development of the sector, Wan Gang, a high-ranking government industrial policy adviser who is often referred to in state media as China's \"father of EV\", said at the same CAAM conference.</p>\n<p>Shares in China's NEV-related companies climbed after the forecast.</p>\n<p>Top battery maker CATL(300750.SZ)&nbsp;gained 3.7%. Hunan Zhongke Electric Co Ltd(300035.SZ), Ningbo Rongbay New Energy Technology Co Ltd(688005.SS), Guangzhou Tinci Materials Technology Co Ltd(002709.SZ)and BYD climbed between 2.9% and 10%.</p>\n<p>Reporting by Yilei Sun and Tony Munroe; Editing by Muralikumar Anantharaman</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LI":"理想汽车","XPEV":"小鹏汽车","002594":"比亚迪","01211":"比亚迪股份","NIO":"蔚来","TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1130200368","content_text":"SHANGHAI, June 18 (Reuters) - China's new energy vehicle (NEV) sales are expected to grow more than 40% each year in the next five years, a senior official at the China Association of Automobile Manufacturers (CAAM) said on Friday.\nFu Bingfeng, executive vice chairman of CAAM, made the remarks at a conference held by the industry body in Shanghai.\nFu's presentation showed that CAAM forecasts sales of NEVs, including battery electric, plug-in hybrid and hydrogen fuel cell vehicles, to hit 1.9 million units this year and 2.7 million vehicles in 2022.\nNEV makers, such as Tesla Inc, Nio Inc, Xpeng Inc and BYD, are expanding manufacturing capacity in China, encouraged by the government's promotion of greener vehicles to cut pollution.\nChina could extend tax exemptions on NEV purchases beyond 2022 to support development of the sector, Wan Gang, a high-ranking government industrial policy adviser who is often referred to in state media as China's \"father of EV\", said at the same CAAM conference.\nShares in China's NEV-related companies climbed after the forecast.\nTop battery maker CATL(300750.SZ) gained 3.7%. Hunan Zhongke Electric Co Ltd(300035.SZ), Ningbo Rongbay New Energy Technology Co Ltd(688005.SS), Guangzhou Tinci Materials Technology Co Ltd(002709.SZ)and BYD climbed between 2.9% and 10%.\nReporting by Yilei Sun and Tony Munroe; Editing by Muralikumar Anantharaman","news_type":1},"isVote":1,"tweetType":1,"viewCount":108,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":161852838,"gmtCreate":1623919263324,"gmtModify":1703823489745,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572681899540620","authorIdStr":"3572681899540620"},"themes":[],"htmlText":"This is an unique concept.. I am sure Apple will risewith this","listText":"This is an unique concept.. I am sure Apple will risewith this","text":"This is an unique concept.. I am sure Apple will risewith this","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/161852838","repostId":"1139981231","repostType":4,"repost":{"id":"1139981231","kind":"news","pubTimestamp":1623910261,"share":"https://ttm.financial/m/news/1139981231?lang=&edition=fundamental","pubTime":"2021-06-17 14:11","market":"us","language":"en","title":"Apple Struggles in Push to Make Healthcare Its Greatest Legacy","url":"https://stock-news.laohu8.com/highlight/detail?id=1139981231","media":"The Wall Street Journal","summary":"Tech giant has envisioned hiring doctors to offer primary care, now focused on Watch\nUnder the leade","content":"<p>Tech giant has envisioned hiring doctors to offer primary care, now focused on Watch</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/cdcc89ff3fd1e1d8ec3f02f3aaf52457\" tg-width=\"1260\" tg-height=\"840\" referrerpolicy=\"no-referrer\"><span>Under the leadership of CEO Tim Cook, Apple has increased its research-and-development budget eightfold to $20 billion annually.</span></p>\n<p>Apple&nbsp;Inc.&nbsp;Chief Executive Tim Cook has said the company’s greatest contribution to mankind will be in health. So far, some Apple initiatives aimed at broadly disrupting the healthcare sector have struggled to gain traction, according to people familiar with them and documents reviewed by The Wall Street Journal.</p>\n<p>Apple has envisioned an audacious plan for healthcare, offering its own primary-care medical service with Apple-employed doctors at its own clinics, according to people familiar with the plan and documents. To test that and other bold healthcare ideas, it took over clinics that catered to its employees and built a team with scores of clinicians, engineers, product designers and others.</p>\n<p>Today those ambitions, which aren’t widely known, have largely stalled as Apple has shifted the focus of its health unit to something it knows well: Selling devices, specifically the Apple Watch, according to people familiar with its strategy.</p>\n<p>The new primary-care service hasn’t gotten off the ground, people familiar with it say. A digital health app launched quietly this year has struggled to keep users engaged, say people familiar with the app and the documents seen by the Journal. Some employees have raised questions internally about the integrity of health data coming from the company’s clinics that has been used to support product development, according to people familiar with their concerns and the documents.</p>\n<p>An Apple spokesman said data integrity is the foundation for all of the company’s innovations. He pointed to the accomplishments of its health team and said the company is still in the early innings of its work in healthcare, adding that new technology such as&nbsp;heart-rate notifications&nbsp;in products like the Apple Watch have improved users’ health. He said data gathered by Apple’s devices is enabling new research that has the potential to improve care.</p>\n<p>“Many of the assertions in this report are based on incomplete, outdated and inaccurate information,” the spokesman said.</p>\n<p>Looking for new markets where technology can improve efficiency and outcomes—and power sales growth—the tech sector has eyed healthcare as an untapped opportunity. Some of tech’s biggest efforts have failed, includingHaven,Amazon.com&nbsp;Inc.’s&nbsp;high-profile partnership with other companies that aimed to reduce healthcare costs. Today, Amazon has a new effort to sell prescriptions and a plan to launch&nbsp;virtual care across 50 states.</p>\n<p>Under Mr. Cook’s leadership, Apple has increased its research-and-development budget eightfold to $20 billion annually, according to its public filings. And besides a smartwatch, the company has released wireless headphones as well as new services. It has also invested heavily in health, autonomous driving and augmented reality, all technically complex, high-stakes areas, meaning that game-changing offerings could be years away or never come.</p>\n<p>Apple can study markets for years before coming up with its own offering, and it sometimes works extensively on new projects or technologies that it ultimately doesn’t bring to market.</p>\n<p>One of its most ambitious healthcare ideas was a plan to offer primary-care medicine, conceived in 2016, according to documents and the people familiar with the plan. An Apple team spent months trying to figure out how the flood of health and wellness data collected from users of its smartwatch, first released in 2015, might be used to improve healthcare, the people said.</p>\n<p>Apple Chief Operating Officer Jeff Williams, who oversees the health team, urged employees to think big. He said Apple should disrupt what he called the “363” and “break fix” model of care in the U.S., where patients may not see their doctors 363 days a year and only visit when something goes wrong, according to people familiar with his ideas.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/837161c8fc0a7b93c5c67936fe293453\" tg-width=\"1260\" tg-height=\"840\"><span>Apple Chief Operating Officer Jeff Williams oversees its health unit.</span></p>\n<p>The team decided one of the best ways to realize that vision was to provide a medical service of its own, said people familiar with the plan, linking data generated by Apple devices with virtual and in-person care provided by Apple doctors. Apple would offer primary care, but also continuous health monitoring as part of a subscription-based personalized health program, according to these people and the documents.</p>\n<p>If Apple could prove that its combination of device sensors, software and services could improve people’s health and lower costs, the company could franchise the model to health systems and even other countries, according to the documents.</p>\n<p>To start, Apple chose to test the service out on its own employees. Apple took over employee health clinics near its headquarters that were being run by a startup and turned them into test beds for new health services, say people familiar with the changes. In 2017 it hired Dr. Sumbul Desai from Stanford University to run the effort, which was given the code name Casper, said the people familiar with the plan.</p>\n<p>The effort continues today, but Apple has struggled to move Casper past a preliminary stage, say people familiar with its operations.</p>\n<p>Dr. Desai’s unit in particular has seen multiple departures by employees who say its culture discourages critical feedback, which is potentially problematic for a unit focused on products and services related to personal health, according to people familiar with its culture and the documents. Some employees expressed concerns that internal data about the clinics’ performance, data that was recently used to support the rollout of a new digital health app, has been inaccurate or compiled haphazardly, according to the documents and people familiar with the data.</p>\n<p>Those issues have been repeatedly voiced to Messrs. Cook and Williams, according to the documents and people familiar with the issues.</p>\n<p>Apple’s spokesman said such criticisms are inaccurate.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/01a35a283d15f6de16455cae846a617b\" tg-width=\"1260\" tg-height=\"840\"><span>Dr. Sumbul Desai runs a team that oversees clinics, handles relations with regulators and spearheads research collaborations.</span></p>\n<p>Employees concerned about the culture pointed to a 2019 meeting during which a midlevel manager raised questions about data, according to people familiar with the meeting and the documents. Dr. Desai responded angrily, leading some present to conclude that critical questions were unwelcome, according to the people and the documents. The manager left Apple weeks later and the episode contributed to her departure, documents show.</p>\n<p>Apple’s spokesman said Dr. Desai spoke to the importance of data integrity in the meeting. “This matter was investigated thoroughly and the allegations could not be substantiated,” the spokesman said. Apple declined to comment on the circumstances of the employee’s departure.</p>\n<p>The spokesman said the company is proud of Dr. Desai’s work and that she has been instrumental in much of its healthcare work.</p>\n<p>Mr. Williams and Dr. Desai didn’t respond to a request for comment and Apple declined to make them available.</p>\n<p>In addition to overseeing the clinics, known as AC Wellness, Dr. Desai’s team handles relations with regulators, spearheads research collaborations and provides clinical expertise on other health products at Apple.</p>\n<p>A recent initiative for Dr. Desai’s team, a digital health app called HealthHabit that is being tested on California-based Apple employees, has struggled with low engagement since the app’s launch roughly six months ago, according to documents and people familiar with the app.</p>\n<p>HealthHabit&nbsp;offers to connect people with clinicians via chat and encourages them to set health challenges such as “I will exercise more this week.” Those with a history of hypertension can be connected to health coaches who can send them a blood-pressure monitor and scale and advise them on healthier habits.</p>\n<p>Half the people who had downloaded it as of May hadn’t enrolled and engagement among many who have enrolled has been low, according to the documents and people familiar with the app.</p>\n<p>Data supporting the app’s hypertension program has caused new concerns among employees about the integrity of internal data and analysis, some of the people said.</p>\n<p>During a presentation for all Apple health employees in March, Mr. Williams praised the clinics’ results in treating hypertension and pointed to them as evidence supporting the HealthHabit app’s potential, according to people who saw the presentation. He suggested that the company may have wider ambitions for the app if it is successful, they said.</p>\n<p>In the meeting, Mr. Williams showed data indicating that 91% of patients in Apple’s clinics with more severe stage-two hypertension improved to healthier stages or normal, according to documents reviewed by the Journal, a figure that some employees feared could overstate the clinics’ success, according to people who attended the meeting and documents.</p>\n<p>Rival companies offering hypertension apps have disclosed lower rates of success. Hello Heart Inc. reported 23% of stage 2 patients saw a significant improvement in blood pressure at 6 weeks. Livongo claimed one-third of patients with stage one hypertension or worse improved to an elevated or normal range in 6 weeks. Mr. Williams’s data didn’t include a time frame, according to the documents.</p>\n<p>The Apple spokesman said that other companies analyze their hypertension data differently and that the data cited by Mr. Williams in the meeting was for an internal pilot, not a product.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Struggles in Push to Make Healthcare Its Greatest Legacy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Struggles in Push to Make Healthcare Its Greatest Legacy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 14:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/apple-struggles-in-push-to-make-healthcare-greatest-legacy-11623832200?mod=hp_lead_pos3><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tech giant has envisioned hiring doctors to offer primary care, now focused on Watch\nUnder the leadership of CEO Tim Cook, Apple has increased its research-and-development budget eightfold to $20 ...</p>\n\n<a href=\"https://www.wsj.com/articles/apple-struggles-in-push-to-make-healthcare-greatest-legacy-11623832200?mod=hp_lead_pos3\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.wsj.com/articles/apple-struggles-in-push-to-make-healthcare-greatest-legacy-11623832200?mod=hp_lead_pos3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139981231","content_text":"Tech giant has envisioned hiring doctors to offer primary care, now focused on Watch\nUnder the leadership of CEO Tim Cook, Apple has increased its research-and-development budget eightfold to $20 billion annually.\nApple Inc. Chief Executive Tim Cook has said the company’s greatest contribution to mankind will be in health. So far, some Apple initiatives aimed at broadly disrupting the healthcare sector have struggled to gain traction, according to people familiar with them and documents reviewed by The Wall Street Journal.\nApple has envisioned an audacious plan for healthcare, offering its own primary-care medical service with Apple-employed doctors at its own clinics, according to people familiar with the plan and documents. To test that and other bold healthcare ideas, it took over clinics that catered to its employees and built a team with scores of clinicians, engineers, product designers and others.\nToday those ambitions, which aren’t widely known, have largely stalled as Apple has shifted the focus of its health unit to something it knows well: Selling devices, specifically the Apple Watch, according to people familiar with its strategy.\nThe new primary-care service hasn’t gotten off the ground, people familiar with it say. A digital health app launched quietly this year has struggled to keep users engaged, say people familiar with the app and the documents seen by the Journal. Some employees have raised questions internally about the integrity of health data coming from the company’s clinics that has been used to support product development, according to people familiar with their concerns and the documents.\nAn Apple spokesman said data integrity is the foundation for all of the company’s innovations. He pointed to the accomplishments of its health team and said the company is still in the early innings of its work in healthcare, adding that new technology such as heart-rate notifications in products like the Apple Watch have improved users’ health. He said data gathered by Apple’s devices is enabling new research that has the potential to improve care.\n“Many of the assertions in this report are based on incomplete, outdated and inaccurate information,” the spokesman said.\nLooking for new markets where technology can improve efficiency and outcomes—and power sales growth—the tech sector has eyed healthcare as an untapped opportunity. Some of tech’s biggest efforts have failed, includingHaven,Amazon.com Inc.’s high-profile partnership with other companies that aimed to reduce healthcare costs. Today, Amazon has a new effort to sell prescriptions and a plan to launch virtual care across 50 states.\nUnder Mr. Cook’s leadership, Apple has increased its research-and-development budget eightfold to $20 billion annually, according to its public filings. And besides a smartwatch, the company has released wireless headphones as well as new services. It has also invested heavily in health, autonomous driving and augmented reality, all technically complex, high-stakes areas, meaning that game-changing offerings could be years away or never come.\nApple can study markets for years before coming up with its own offering, and it sometimes works extensively on new projects or technologies that it ultimately doesn’t bring to market.\nOne of its most ambitious healthcare ideas was a plan to offer primary-care medicine, conceived in 2016, according to documents and the people familiar with the plan. An Apple team spent months trying to figure out how the flood of health and wellness data collected from users of its smartwatch, first released in 2015, might be used to improve healthcare, the people said.\nApple Chief Operating Officer Jeff Williams, who oversees the health team, urged employees to think big. He said Apple should disrupt what he called the “363” and “break fix” model of care in the U.S., where patients may not see their doctors 363 days a year and only visit when something goes wrong, according to people familiar with his ideas.\nApple Chief Operating Officer Jeff Williams oversees its health unit.\nThe team decided one of the best ways to realize that vision was to provide a medical service of its own, said people familiar with the plan, linking data generated by Apple devices with virtual and in-person care provided by Apple doctors. Apple would offer primary care, but also continuous health monitoring as part of a subscription-based personalized health program, according to these people and the documents.\nIf Apple could prove that its combination of device sensors, software and services could improve people’s health and lower costs, the company could franchise the model to health systems and even other countries, according to the documents.\nTo start, Apple chose to test the service out on its own employees. Apple took over employee health clinics near its headquarters that were being run by a startup and turned them into test beds for new health services, say people familiar with the changes. In 2017 it hired Dr. Sumbul Desai from Stanford University to run the effort, which was given the code name Casper, said the people familiar with the plan.\nThe effort continues today, but Apple has struggled to move Casper past a preliminary stage, say people familiar with its operations.\nDr. Desai’s unit in particular has seen multiple departures by employees who say its culture discourages critical feedback, which is potentially problematic for a unit focused on products and services related to personal health, according to people familiar with its culture and the documents. Some employees expressed concerns that internal data about the clinics’ performance, data that was recently used to support the rollout of a new digital health app, has been inaccurate or compiled haphazardly, according to the documents and people familiar with the data.\nThose issues have been repeatedly voiced to Messrs. Cook and Williams, according to the documents and people familiar with the issues.\nApple’s spokesman said such criticisms are inaccurate.\nDr. Sumbul Desai runs a team that oversees clinics, handles relations with regulators and spearheads research collaborations.\nEmployees concerned about the culture pointed to a 2019 meeting during which a midlevel manager raised questions about data, according to people familiar with the meeting and the documents. Dr. Desai responded angrily, leading some present to conclude that critical questions were unwelcome, according to the people and the documents. The manager left Apple weeks later and the episode contributed to her departure, documents show.\nApple’s spokesman said Dr. Desai spoke to the importance of data integrity in the meeting. “This matter was investigated thoroughly and the allegations could not be substantiated,” the spokesman said. Apple declined to comment on the circumstances of the employee’s departure.\nThe spokesman said the company is proud of Dr. Desai’s work and that she has been instrumental in much of its healthcare work.\nMr. Williams and Dr. Desai didn’t respond to a request for comment and Apple declined to make them available.\nIn addition to overseeing the clinics, known as AC Wellness, Dr. Desai’s team handles relations with regulators, spearheads research collaborations and provides clinical expertise on other health products at Apple.\nA recent initiative for Dr. Desai’s team, a digital health app called HealthHabit that is being tested on California-based Apple employees, has struggled with low engagement since the app’s launch roughly six months ago, according to documents and people familiar with the app.\nHealthHabit offers to connect people with clinicians via chat and encourages them to set health challenges such as “I will exercise more this week.” Those with a history of hypertension can be connected to health coaches who can send them a blood-pressure monitor and scale and advise them on healthier habits.\nHalf the people who had downloaded it as of May hadn’t enrolled and engagement among many who have enrolled has been low, according to the documents and people familiar with the app.\nData supporting the app’s hypertension program has caused new concerns among employees about the integrity of internal data and analysis, some of the people said.\nDuring a presentation for all Apple health employees in March, Mr. Williams praised the clinics’ results in treating hypertension and pointed to them as evidence supporting the HealthHabit app’s potential, according to people who saw the presentation. He suggested that the company may have wider ambitions for the app if it is successful, they said.\nIn the meeting, Mr. Williams showed data indicating that 91% of patients in Apple’s clinics with more severe stage-two hypertension improved to healthier stages or normal, according to documents reviewed by the Journal, a figure that some employees feared could overstate the clinics’ success, according to people who attended the meeting and documents.\nRival companies offering hypertension apps have disclosed lower rates of success. Hello Heart Inc. reported 23% of stage 2 patients saw a significant improvement in blood pressure at 6 weeks. Livongo claimed one-third of patients with stage one hypertension or worse improved to an elevated or normal range in 6 weeks. Mr. Williams’s data didn’t include a time frame, according to the documents.\nThe Apple spokesman said that other companies analyze their hypertension data differently and that the data cited by Mr. Williams in the meeting was for an internal pilot, not a product.","news_type":1},"isVote":1,"tweetType":1,"viewCount":214,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163364552,"gmtCreate":1623860017076,"gmtModify":1703821810832,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572681899540620","authorIdStr":"3572681899540620"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/163364552","repostId":"1109608534","repostType":4,"repost":{"id":"1109608534","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623852639,"share":"https://ttm.financial/m/news/1109608534?lang=&edition=fundamental","pubTime":"2021-06-16 22:10","market":"us","language":"en","title":"Cruise Stocks Gain As Wolfe Upgrades On Improving Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=1109608534","media":"Tiger Newspress","summary":"Shares of the largest cruise operators, namely Royal Caribbean, Norwegian Cruise Line and Carnival, ","content":"<p>Shares of the largest cruise operators, namely Royal Caribbean, Norwegian Cruise Line&nbsp;and Carnival, were up in&nbsp;moring&nbsp;trading on an upgrade by Wolfe Research.</p>\n<p>Early signs of customer demand for the return of vacations at sea should make investors more bullish on cruise stocks, according to Wolfe Research.</p>\n<p>The cruise industry was one of the hardest hit by the pandemic, with voyages being stopped around the world, but with widespread vaccinations in the U.S., the major companies have plans toresume American operations over the summer.</p>\n<p>Analyst Greg Badishkanian upgraded&nbsp;Carnival,Royal Caribbean&nbsp;and&nbsp;Norwegian Cruise Line Holdingsto outperform from peer perform, saying in a note to clients on Wednesday that early indications pointed to a strong restart for the industry.</p>\n<p>“Our checks suggest improving booking / pricing trends out of North America over the past month, with stronger trends over the past week. While there is some lingering uncertainty surrounding the U.S. restart (CDC / Florida, etc.), we view those unknowns as largely transitory when viewed against the broader reopening backdrop,” the note said.</p>\n<p>Bookings and demand are running ahead of pre-pandemic levels, according to Wolfe.</p>\n<p>“Cumulative 2022 bookings are now up approx. +10% to +15% versus 2019 levels with signs of improving 1Q demand (especially in January). Pricing is up in the +15% to 25% range vs. 2019 before factoring in [future cruise credits],” the note said.</p>\n<p>Wolfe has price targets of $32 per share for Carnival, $96 for Royal Caribbean and $36 for Norwegian. Those represent upside of roughly 12%, 8% and 17%, respectively.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cruise Stocks Gain As Wolfe Upgrades On Improving Demand</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCruise Stocks Gain As Wolfe Upgrades On Improving Demand\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-16 22:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of the largest cruise operators, namely Royal Caribbean, Norwegian Cruise Line&nbsp;and Carnival, were up in&nbsp;moring&nbsp;trading on an upgrade by Wolfe Research.</p>\n<p>Early signs of customer demand for the return of vacations at sea should make investors more bullish on cruise stocks, according to Wolfe Research.</p>\n<p>The cruise industry was one of the hardest hit by the pandemic, with voyages being stopped around the world, but with widespread vaccinations in the U.S., the major companies have plans toresume American operations over the summer.</p>\n<p>Analyst Greg Badishkanian upgraded&nbsp;Carnival,Royal Caribbean&nbsp;and&nbsp;Norwegian Cruise Line Holdingsto outperform from peer perform, saying in a note to clients on Wednesday that early indications pointed to a strong restart for the industry.</p>\n<p>“Our checks suggest improving booking / pricing trends out of North America over the past month, with stronger trends over the past week. While there is some lingering uncertainty surrounding the U.S. restart (CDC / Florida, etc.), we view those unknowns as largely transitory when viewed against the broader reopening backdrop,” the note said.</p>\n<p>Bookings and demand are running ahead of pre-pandemic levels, according to Wolfe.</p>\n<p>“Cumulative 2022 bookings are now up approx. +10% to +15% versus 2019 levels with signs of improving 1Q demand (especially in January). Pricing is up in the +15% to 25% range vs. 2019 before factoring in [future cruise credits],” the note said.</p>\n<p>Wolfe has price targets of $32 per share for Carnival, $96 for Royal Caribbean and $36 for Norwegian. Those represent upside of roughly 12%, 8% and 17%, respectively.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RCL":"皇家加勒比邮轮","CCL":"嘉年华邮轮","NCLH":"挪威邮轮"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1109608534","content_text":"Shares of the largest cruise operators, namely Royal Caribbean, Norwegian Cruise Line and Carnival, were up in moring trading on an upgrade by Wolfe Research.\nEarly signs of customer demand for the return of vacations at sea should make investors more bullish on cruise stocks, according to Wolfe Research.\nThe cruise industry was one of the hardest hit by the pandemic, with voyages being stopped around the world, but with widespread vaccinations in the U.S., the major companies have plans toresume American operations over the summer.\nAnalyst Greg Badishkanian upgraded Carnival,Royal Caribbean and Norwegian Cruise Line Holdingsto outperform from peer perform, saying in a note to clients on Wednesday that early indications pointed to a strong restart for the industry.\n“Our checks suggest improving booking / pricing trends out of North America over the past month, with stronger trends over the past week. While there is some lingering uncertainty surrounding the U.S. restart (CDC / Florida, etc.), we view those unknowns as largely transitory when viewed against the broader reopening backdrop,” the note said.\nBookings and demand are running ahead of pre-pandemic levels, according to Wolfe.\n“Cumulative 2022 bookings are now up approx. +10% to +15% versus 2019 levels with signs of improving 1Q demand (especially in January). Pricing is up in the +15% to 25% range vs. 2019 before factoring in [future cruise credits],” the note said.\nWolfe has price targets of $32 per share for Carnival, $96 for Royal Caribbean and $36 for Norwegian. Those represent upside of roughly 12%, 8% and 17%, respectively.","news_type":1},"isVote":1,"tweetType":1,"viewCount":81,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163362665,"gmtCreate":1623859981057,"gmtModify":1703821808553,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572681899540620","authorIdStr":"3572681899540620"},"themes":[],"htmlText":"Agree","listText":"Agree","text":"Agree","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/163362665","repostId":"1137784542","repostType":4,"repost":{"id":"1137784542","kind":"news","pubTimestamp":1623856057,"share":"https://ttm.financial/m/news/1137784542?lang=&edition=fundamental","pubTime":"2021-06-16 23:07","market":"us","language":"en","title":"Buy Coinbase on the dip for a long-term opportunity on the crypto economy, Canaccord says","url":"https://stock-news.laohu8.com/highlight/detail?id=1137784542","media":"cnbc","summary":"Coinbase’s price may fluctuate alongside the value of bitcoin in the short-term, but Canaccord is be","content":"<div>\n<p>Coinbase’s price may fluctuate alongside the value of bitcoin in the short-term, but Canaccord is betting on the future of blockchain technology and initiating coverage of the crypto exchange as a buy...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/16/cryptocurrency-buy-the-dip-on-coinbase-says-canaccord.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buy Coinbase on the dip for a long-term opportunity on the crypto economy, Canaccord says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuy Coinbase on the dip for a long-term opportunity on the crypto economy, Canaccord says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 23:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/16/cryptocurrency-buy-the-dip-on-coinbase-says-canaccord.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Coinbase’s price may fluctuate alongside the value of bitcoin in the short-term, but Canaccord is betting on the future of blockchain technology and initiating coverage of the crypto exchange as a buy...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/16/cryptocurrency-buy-the-dip-on-coinbase-says-canaccord.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"COIN":"Coinbase Global, Inc."},"source_url":"https://www.cnbc.com/2021/06/16/cryptocurrency-buy-the-dip-on-coinbase-says-canaccord.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1137784542","content_text":"Coinbase’s price may fluctuate alongside the value of bitcoin in the short-term, but Canaccord is betting on the future of blockchain technology and initiating coverage of the crypto exchange as a buy.\nThe largest U.S. cryptocurrency exchange’s stock, which last traded at around $233, made itspublic debut in mid-Apriland fell sharply with the price of bitcoin in late May. Bitcoin is currently trading around $39,000 following a rollercoaster month of trading after itsprice drop almost a month ago.\nCoinbase’s revenue is largely driven by trading fees, 81% of which come from retail trading and 5% from institutional trading, according to Canaccord. It has the highest trading fees across crypto exchanges, the bank found.\nStill, Canaccord said it’s confident Coinbase’s business will ultimately expand beyond retail trading and into emerging opportunities for the blockchain – which could include supporting new protocols beyond bitcoin and Ethereum, decentralized finance and cloud solutions – and that crypto exchange will be a “super on-ramp” into that new world.\nCanaccord set its one-year price target on the stock at $285, which is 12 times its 2022 enterprise value-to-sales estimate.Enterprise value-to-salesis a ratio that measures a firm’s value versus its sales revenue.\n“Market share and technology leaders that leverage their positions to drive innovation via creating new customer behaviors present some of most compelling, long-term value propositions in the market,” the bank said. “Although we will see ongoing volatility, we don’t think that comparing the longer-term potential of the blockchain and digital assets to what we have seen in ecommerce is off the mark.”\nThe analysts noted that Coinbase shares are likely to see headwinds in the short term, based on crypto spot price volatility so far in June.\n“If we are in a bitcoin holding pattern here for a while, COIN could likely see sequentially weaker financial performance,” they said.\nStill, “we remain biased to the upside on bitcoin medium term and believe that resilience and elegance in the blockchain provide a great foundation for the entirety of digital assets from here,” the analysts wrote.\nCanaccord’s analysts highlighted bitcoin’s increasingly vertical supply curve – that is, the fact that quantities are limited, regardless of how much investors are willing to pay – as well as institutional interest in digital assets, comparative valuation to other stores of value, and “importantly what we view as an inevitable U.S. ETF.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":97,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114238441,"gmtCreate":1623074908983,"gmtModify":1704195557315,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572681899540620","authorIdStr":"3572681899540620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>Guys hold on to this gold..","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>Guys hold on to this gold..","text":"$BioNTech SE(BNTX)$Guys hold on to this gold..","images":[{"img":"https://static.tigerbbs.com/d6058e7cc5210c277adf9f5a08555ea7","width":"1284","height":"2223"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/114238441","isVote":1,"tweetType":1,"viewCount":390,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":106387964,"gmtCreate":1620088633658,"gmtModify":1704338414503,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572681899540620","authorIdStr":"3572681899540620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>this will go to 1000 $ soon","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>this will go to 1000 $ soon","text":"$BioNTech SE(BNTX)$this will go to 1000 $ soon","images":[{"img":"https://static.tigerbbs.com/4d1d896b23fa543c75c4056bd9f8a161","width":"720","height":"1280"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/106387964","isVote":1,"tweetType":1,"viewCount":419,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":100289865,"gmtCreate":1619617147357,"gmtModify":1704726854496,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572681899540620","authorIdStr":"3572681899540620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>I&nbsp; consider Pfizer BionTech Vaccine as&nbsp;the best Covid 19 vaccine the world has...","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>I&nbsp; consider Pfizer BionTech Vaccine as&nbsp;the best Covid 19 vaccine the world has...","text":"$BioNTech SE(BNTX)$I consider Pfizer BionTech Vaccine as the best Covid 19 vaccine the world has...","images":[{"img":"https://static.tigerbbs.com/d167ca4060ecf218d3a99581741a4a90","width":"720","height":"1280"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/100289865","isVote":1,"tweetType":1,"viewCount":357,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":890181635,"gmtCreate":1628086861327,"gmtModify":1703501018125,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572681899540620","idStr":"3572681899540620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>To the moon target 1000","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>To the moon target 1000","text":"$BioNTech SE(BNTX)$To the moon target 1000","images":[{"img":"https://static.tigerbbs.com/719384725b70893f7f10e49c0f12db2c","width":"1284","height":"2457"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/890181635","isVote":1,"tweetType":1,"viewCount":171,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":106387964,"gmtCreate":1620088633658,"gmtModify":1704338414503,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572681899540620","idStr":"3572681899540620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>this will go to 1000 $ soon","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>this will go to 1000 $ soon","text":"$BioNTech SE(BNTX)$this will go to 1000 $ soon","images":[{"img":"https://static.tigerbbs.com/4d1d896b23fa543c75c4056bd9f8a161","width":"720","height":"1280"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/106387964","isVote":1,"tweetType":1,"viewCount":419,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":898420587,"gmtCreate":1628518132149,"gmtModify":1703507454342,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572681899540620","idStr":"3572681899540620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>Next target 500","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>Next target 500","text":"$BioNTech SE(BNTX)$Next target 500","images":[{"img":"https://static.tigerbbs.com/a045f2af6246ecbc78e64cab1f82193a","width":"1284","height":"2457"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/898420587","isVote":1,"tweetType":1,"viewCount":505,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":898760230,"gmtCreate":1628522412820,"gmtModify":1703507584548,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572681899540620","idStr":"3572681899540620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>Yes yes yes","listText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>Yes yes yes","text":"$Moderna, Inc.(MRNA)$Yes yes yes","images":[{"img":"https://static.tigerbbs.com/3b8a7274296476e2351a327a7d00daf9","width":"1284","height":"2223"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/898760230","isVote":1,"tweetType":1,"viewCount":310,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":899996408,"gmtCreate":1628149537304,"gmtModify":1703502122376,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572681899540620","idStr":"3572681899540620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>More more more","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>More more more","text":"$BioNTech SE(BNTX)$More more more","images":[{"img":"https://static.tigerbbs.com/abc428ee0703444be2d93452f8ac20e7","width":"1284","height":"2223"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/899996408","isVote":1,"tweetType":1,"viewCount":332,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":114238441,"gmtCreate":1623074908983,"gmtModify":1704195557315,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572681899540620","idStr":"3572681899540620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>Guys hold on to this gold..","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>Guys hold on to this gold..","text":"$BioNTech SE(BNTX)$Guys hold on to this gold..","images":[{"img":"https://static.tigerbbs.com/d6058e7cc5210c277adf9f5a08555ea7","width":"1284","height":"2223"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/114238441","isVote":1,"tweetType":1,"viewCount":390,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":898229371,"gmtCreate":1628502320293,"gmtModify":1703507170415,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572681899540620","idStr":"3572681899540620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MVST\">$Microvast Holdings, Inc.(MVST)$</a>This is a hidden gem","listText":"<a href=\"https://laohu8.com/S/MVST\">$Microvast Holdings, Inc.(MVST)$</a>This is a hidden gem","text":"$Microvast Holdings, Inc.(MVST)$This is a hidden gem","images":[{"img":"https://static.tigerbbs.com/a5522baaa5c715951a2f57095a2edf48","width":"1284","height":"2223"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/898229371","isVote":1,"tweetType":1,"viewCount":274,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":125596029,"gmtCreate":1624678974361,"gmtModify":1703843472809,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572681899540620","idStr":"3572681899540620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SPCE\">$Virgin Galactic(SPCE)$</a>Going to moon","listText":"<a href=\"https://laohu8.com/S/SPCE\">$Virgin Galactic(SPCE)$</a>Going to moon","text":"$Virgin Galactic(SPCE)$Going to moon","images":[{"img":"https://static.tigerbbs.com/c3f985051b5ac72ac3116795e26adba4","width":"1284","height":"2223"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/125596029","isVote":1,"tweetType":1,"viewCount":203,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":166890269,"gmtCreate":1624000000151,"gmtModify":1703826186988,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572681899540620","idStr":"3572681899540620"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166890269","repostId":"1130200368","repostType":4,"repost":{"id":"1130200368","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623992866,"share":"https://ttm.financial/m/news/1130200368?lang=&edition=fundamental","pubTime":"2021-06-18 13:07","market":"hk","language":"en","title":"China new energy vehicle sales to grow over 40%/yr in next 5 yrs -industry body","url":"https://stock-news.laohu8.com/highlight/detail?id=1130200368","media":"Reuters","summary":"SHANGHAI, June 18  - China's new energy vehicle  sales are expected to grow more than 40% each year in the next five years, a senior official at the China Association of Automobile Manufacturers  said on Friday.Fu Bingfeng, executive vice chairman of CAAM, made the remarks at a conference held by the industry body in Shanghai.Fu's presentation showed that CAAM forecasts sales of NEVs, including battery electric, plug-in hybrid and hydrogen fuel cell vehicles, to hit 1.9 million units this year a","content":"<p>SHANGHAI, June 18 (Reuters) - China's new energy vehicle (NEV) sales are expected to grow more than 40% each year in the next five years, a senior official at the China Association of Automobile Manufacturers (CAAM) said on Friday.</p>\n<p>Fu Bingfeng, executive vice chairman of CAAM, made the remarks at a conference held by the industry body in Shanghai.</p>\n<p>Fu's presentation showed that CAAM forecasts sales of NEVs, including battery electric, plug-in hybrid and hydrogen fuel cell vehicles, to hit 1.9 million units this year and 2.7 million vehicles in 2022.</p>\n<p>NEV makers, such as Tesla Inc, Nio Inc, Xpeng Inc&nbsp;and BYD, are expanding manufacturing capacity in China, encouraged by the government's promotion of greener vehicles to cut pollution.</p>\n<p>China could extend tax exemptions on NEV purchases beyond 2022 to support development of the sector, Wan Gang, a high-ranking government industrial policy adviser who is often referred to in state media as China's \"father of EV\", said at the same CAAM conference.</p>\n<p>Shares in China's NEV-related companies climbed after the forecast.</p>\n<p>Top battery maker CATL(300750.SZ)&nbsp;gained 3.7%. Hunan Zhongke Electric Co Ltd(300035.SZ), Ningbo Rongbay New Energy Technology Co Ltd(688005.SS), Guangzhou Tinci Materials Technology Co Ltd(002709.SZ)and BYD climbed between 2.9% and 10%.</p>\n<p>Reporting by Yilei Sun and Tony Munroe; Editing by Muralikumar Anantharaman</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China new energy vehicle sales to grow over 40%/yr in next 5 yrs -industry body</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina new energy vehicle sales to grow over 40%/yr in next 5 yrs -industry body\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-18 13:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SHANGHAI, June 18 (Reuters) - China's new energy vehicle (NEV) sales are expected to grow more than 40% each year in the next five years, a senior official at the China Association of Automobile Manufacturers (CAAM) said on Friday.</p>\n<p>Fu Bingfeng, executive vice chairman of CAAM, made the remarks at a conference held by the industry body in Shanghai.</p>\n<p>Fu's presentation showed that CAAM forecasts sales of NEVs, including battery electric, plug-in hybrid and hydrogen fuel cell vehicles, to hit 1.9 million units this year and 2.7 million vehicles in 2022.</p>\n<p>NEV makers, such as Tesla Inc, Nio Inc, Xpeng Inc&nbsp;and BYD, are expanding manufacturing capacity in China, encouraged by the government's promotion of greener vehicles to cut pollution.</p>\n<p>China could extend tax exemptions on NEV purchases beyond 2022 to support development of the sector, Wan Gang, a high-ranking government industrial policy adviser who is often referred to in state media as China's \"father of EV\", said at the same CAAM conference.</p>\n<p>Shares in China's NEV-related companies climbed after the forecast.</p>\n<p>Top battery maker CATL(300750.SZ)&nbsp;gained 3.7%. Hunan Zhongke Electric Co Ltd(300035.SZ), Ningbo Rongbay New Energy Technology Co Ltd(688005.SS), Guangzhou Tinci Materials Technology Co Ltd(002709.SZ)and BYD climbed between 2.9% and 10%.</p>\n<p>Reporting by Yilei Sun and Tony Munroe; Editing by Muralikumar Anantharaman</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LI":"理想汽车","XPEV":"小鹏汽车","002594":"比亚迪","01211":"比亚迪股份","NIO":"蔚来","TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1130200368","content_text":"SHANGHAI, June 18 (Reuters) - China's new energy vehicle (NEV) sales are expected to grow more than 40% each year in the next five years, a senior official at the China Association of Automobile Manufacturers (CAAM) said on Friday.\nFu Bingfeng, executive vice chairman of CAAM, made the remarks at a conference held by the industry body in Shanghai.\nFu's presentation showed that CAAM forecasts sales of NEVs, including battery electric, plug-in hybrid and hydrogen fuel cell vehicles, to hit 1.9 million units this year and 2.7 million vehicles in 2022.\nNEV makers, such as Tesla Inc, Nio Inc, Xpeng Inc and BYD, are expanding manufacturing capacity in China, encouraged by the government's promotion of greener vehicles to cut pollution.\nChina could extend tax exemptions on NEV purchases beyond 2022 to support development of the sector, Wan Gang, a high-ranking government industrial policy adviser who is often referred to in state media as China's \"father of EV\", said at the same CAAM conference.\nShares in China's NEV-related companies climbed after the forecast.\nTop battery maker CATL(300750.SZ) gained 3.7%. Hunan Zhongke Electric Co Ltd(300035.SZ), Ningbo Rongbay New Energy Technology Co Ltd(688005.SS), Guangzhou Tinci Materials Technology Co Ltd(002709.SZ)and BYD climbed between 2.9% and 10%.\nReporting by Yilei Sun and Tony Munroe; Editing by Muralikumar Anantharaman","news_type":1},"isVote":1,"tweetType":1,"viewCount":108,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":100289865,"gmtCreate":1619617147357,"gmtModify":1704726854496,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572681899540620","idStr":"3572681899540620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>I&nbsp; consider Pfizer BionTech Vaccine as&nbsp;the best Covid 19 vaccine the world has...","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>I&nbsp; consider Pfizer BionTech Vaccine as&nbsp;the best Covid 19 vaccine the world has...","text":"$BioNTech SE(BNTX)$I consider Pfizer BionTech Vaccine as the best Covid 19 vaccine the world has...","images":[{"img":"https://static.tigerbbs.com/d167ca4060ecf218d3a99581741a4a90","width":"720","height":"1280"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/100289865","isVote":1,"tweetType":1,"viewCount":357,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":163362665,"gmtCreate":1623859981057,"gmtModify":1703821808553,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572681899540620","idStr":"3572681899540620"},"themes":[],"htmlText":"Agree","listText":"Agree","text":"Agree","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/163362665","repostId":"1137784542","repostType":4,"isVote":1,"tweetType":1,"viewCount":97,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898780954,"gmtCreate":1628521898678,"gmtModify":1703507568805,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572681899540620","idStr":"3572681899540620"},"themes":[],"htmlText":"Share price is more dependent&nbsp;forwarded earning based P/E and not current.","listText":"Share price is more dependent&nbsp;forwarded earning based P/E and not current.","text":"Share price is more dependent forwarded earning based P/E and not current.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/898780954","repostId":"898714123","repostType":1,"repost":{"id":898714123,"gmtCreate":1628521757062,"gmtModify":1703507566677,"author":{"id":"333474855162240","authorId":"333474855162240","name":"夏禾木","avatar":"https://static.laohu8.com/41c2bd4f64df098421e74aab2f345a3b","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"333474855162240","idStr":"333474855162240"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>我覺得我沒有格局，留下了沒有格局的淚水……我知道炒股不能看市盈率，但真的太嚇人了……想買又不敢買[流淚]&nbsp;下來點 讓我上個車行不行……","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>我覺得我沒有格局，留下了沒有格局的淚水……我知道炒股不能看市盈率，但真的太嚇人了……想買又不敢買[流淚]&nbsp;下來點 讓我上個車行不行……","text":"$BioNTech SE(BNTX)$我覺得我沒有格局，留下了沒有格局的淚水……我知道炒股不能看市盈率，但真的太嚇人了……想買又不敢買[流淚] 下來點 讓我上個車行不行……","images":[{"img":"https://static.tigerbbs.com/56a757c278c66ce146f219aef28916f1","width":"828","height":"1792"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/898714123","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":236,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166893327,"gmtCreate":1624000072569,"gmtModify":1703826189270,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572681899540620","idStr":"3572681899540620"},"themes":[],"htmlText":"Thanks, noted","listText":"Thanks, noted","text":"Thanks, noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166893327","repostId":"2144742697","repostType":4,"isVote":1,"tweetType":1,"viewCount":248,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":161852838,"gmtCreate":1623919263324,"gmtModify":1703823489745,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572681899540620","idStr":"3572681899540620"},"themes":[],"htmlText":"This is an unique concept.. I am sure Apple will risewith this","listText":"This is an unique concept.. I am sure Apple will risewith this","text":"This is an unique concept.. I am sure Apple will risewith this","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/161852838","repostId":"1139981231","repostType":4,"repost":{"id":"1139981231","kind":"news","pubTimestamp":1623910261,"share":"https://ttm.financial/m/news/1139981231?lang=&edition=fundamental","pubTime":"2021-06-17 14:11","market":"us","language":"en","title":"Apple Struggles in Push to Make Healthcare Its Greatest Legacy","url":"https://stock-news.laohu8.com/highlight/detail?id=1139981231","media":"The Wall Street Journal","summary":"Tech giant has envisioned hiring doctors to offer primary care, now focused on Watch\nUnder the leade","content":"<p>Tech giant has envisioned hiring doctors to offer primary care, now focused on Watch</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/cdcc89ff3fd1e1d8ec3f02f3aaf52457\" tg-width=\"1260\" tg-height=\"840\" referrerpolicy=\"no-referrer\"><span>Under the leadership of CEO Tim Cook, Apple has increased its research-and-development budget eightfold to $20 billion annually.</span></p>\n<p>Apple&nbsp;Inc.&nbsp;Chief Executive Tim Cook has said the company’s greatest contribution to mankind will be in health. So far, some Apple initiatives aimed at broadly disrupting the healthcare sector have struggled to gain traction, according to people familiar with them and documents reviewed by The Wall Street Journal.</p>\n<p>Apple has envisioned an audacious plan for healthcare, offering its own primary-care medical service with Apple-employed doctors at its own clinics, according to people familiar with the plan and documents. To test that and other bold healthcare ideas, it took over clinics that catered to its employees and built a team with scores of clinicians, engineers, product designers and others.</p>\n<p>Today those ambitions, which aren’t widely known, have largely stalled as Apple has shifted the focus of its health unit to something it knows well: Selling devices, specifically the Apple Watch, according to people familiar with its strategy.</p>\n<p>The new primary-care service hasn’t gotten off the ground, people familiar with it say. A digital health app launched quietly this year has struggled to keep users engaged, say people familiar with the app and the documents seen by the Journal. Some employees have raised questions internally about the integrity of health data coming from the company’s clinics that has been used to support product development, according to people familiar with their concerns and the documents.</p>\n<p>An Apple spokesman said data integrity is the foundation for all of the company’s innovations. He pointed to the accomplishments of its health team and said the company is still in the early innings of its work in healthcare, adding that new technology such as&nbsp;heart-rate notifications&nbsp;in products like the Apple Watch have improved users’ health. He said data gathered by Apple’s devices is enabling new research that has the potential to improve care.</p>\n<p>“Many of the assertions in this report are based on incomplete, outdated and inaccurate information,” the spokesman said.</p>\n<p>Looking for new markets where technology can improve efficiency and outcomes—and power sales growth—the tech sector has eyed healthcare as an untapped opportunity. Some of tech’s biggest efforts have failed, includingHaven,Amazon.com&nbsp;Inc.’s&nbsp;high-profile partnership with other companies that aimed to reduce healthcare costs. Today, Amazon has a new effort to sell prescriptions and a plan to launch&nbsp;virtual care across 50 states.</p>\n<p>Under Mr. Cook’s leadership, Apple has increased its research-and-development budget eightfold to $20 billion annually, according to its public filings. And besides a smartwatch, the company has released wireless headphones as well as new services. It has also invested heavily in health, autonomous driving and augmented reality, all technically complex, high-stakes areas, meaning that game-changing offerings could be years away or never come.</p>\n<p>Apple can study markets for years before coming up with its own offering, and it sometimes works extensively on new projects or technologies that it ultimately doesn’t bring to market.</p>\n<p>One of its most ambitious healthcare ideas was a plan to offer primary-care medicine, conceived in 2016, according to documents and the people familiar with the plan. An Apple team spent months trying to figure out how the flood of health and wellness data collected from users of its smartwatch, first released in 2015, might be used to improve healthcare, the people said.</p>\n<p>Apple Chief Operating Officer Jeff Williams, who oversees the health team, urged employees to think big. He said Apple should disrupt what he called the “363” and “break fix” model of care in the U.S., where patients may not see their doctors 363 days a year and only visit when something goes wrong, according to people familiar with his ideas.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/837161c8fc0a7b93c5c67936fe293453\" tg-width=\"1260\" tg-height=\"840\"><span>Apple Chief Operating Officer Jeff Williams oversees its health unit.</span></p>\n<p>The team decided one of the best ways to realize that vision was to provide a medical service of its own, said people familiar with the plan, linking data generated by Apple devices with virtual and in-person care provided by Apple doctors. Apple would offer primary care, but also continuous health monitoring as part of a subscription-based personalized health program, according to these people and the documents.</p>\n<p>If Apple could prove that its combination of device sensors, software and services could improve people’s health and lower costs, the company could franchise the model to health systems and even other countries, according to the documents.</p>\n<p>To start, Apple chose to test the service out on its own employees. Apple took over employee health clinics near its headquarters that were being run by a startup and turned them into test beds for new health services, say people familiar with the changes. In 2017 it hired Dr. Sumbul Desai from Stanford University to run the effort, which was given the code name Casper, said the people familiar with the plan.</p>\n<p>The effort continues today, but Apple has struggled to move Casper past a preliminary stage, say people familiar with its operations.</p>\n<p>Dr. Desai’s unit in particular has seen multiple departures by employees who say its culture discourages critical feedback, which is potentially problematic for a unit focused on products and services related to personal health, according to people familiar with its culture and the documents. Some employees expressed concerns that internal data about the clinics’ performance, data that was recently used to support the rollout of a new digital health app, has been inaccurate or compiled haphazardly, according to the documents and people familiar with the data.</p>\n<p>Those issues have been repeatedly voiced to Messrs. Cook and Williams, according to the documents and people familiar with the issues.</p>\n<p>Apple’s spokesman said such criticisms are inaccurate.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/01a35a283d15f6de16455cae846a617b\" tg-width=\"1260\" tg-height=\"840\"><span>Dr. Sumbul Desai runs a team that oversees clinics, handles relations with regulators and spearheads research collaborations.</span></p>\n<p>Employees concerned about the culture pointed to a 2019 meeting during which a midlevel manager raised questions about data, according to people familiar with the meeting and the documents. Dr. Desai responded angrily, leading some present to conclude that critical questions were unwelcome, according to the people and the documents. The manager left Apple weeks later and the episode contributed to her departure, documents show.</p>\n<p>Apple’s spokesman said Dr. Desai spoke to the importance of data integrity in the meeting. “This matter was investigated thoroughly and the allegations could not be substantiated,” the spokesman said. Apple declined to comment on the circumstances of the employee’s departure.</p>\n<p>The spokesman said the company is proud of Dr. Desai’s work and that she has been instrumental in much of its healthcare work.</p>\n<p>Mr. Williams and Dr. Desai didn’t respond to a request for comment and Apple declined to make them available.</p>\n<p>In addition to overseeing the clinics, known as AC Wellness, Dr. Desai’s team handles relations with regulators, spearheads research collaborations and provides clinical expertise on other health products at Apple.</p>\n<p>A recent initiative for Dr. Desai’s team, a digital health app called HealthHabit that is being tested on California-based Apple employees, has struggled with low engagement since the app’s launch roughly six months ago, according to documents and people familiar with the app.</p>\n<p>HealthHabit&nbsp;offers to connect people with clinicians via chat and encourages them to set health challenges such as “I will exercise more this week.” Those with a history of hypertension can be connected to health coaches who can send them a blood-pressure monitor and scale and advise them on healthier habits.</p>\n<p>Half the people who had downloaded it as of May hadn’t enrolled and engagement among many who have enrolled has been low, according to the documents and people familiar with the app.</p>\n<p>Data supporting the app’s hypertension program has caused new concerns among employees about the integrity of internal data and analysis, some of the people said.</p>\n<p>During a presentation for all Apple health employees in March, Mr. Williams praised the clinics’ results in treating hypertension and pointed to them as evidence supporting the HealthHabit app’s potential, according to people who saw the presentation. He suggested that the company may have wider ambitions for the app if it is successful, they said.</p>\n<p>In the meeting, Mr. Williams showed data indicating that 91% of patients in Apple’s clinics with more severe stage-two hypertension improved to healthier stages or normal, according to documents reviewed by the Journal, a figure that some employees feared could overstate the clinics’ success, according to people who attended the meeting and documents.</p>\n<p>Rival companies offering hypertension apps have disclosed lower rates of success. Hello Heart Inc. reported 23% of stage 2 patients saw a significant improvement in blood pressure at 6 weeks. Livongo claimed one-third of patients with stage one hypertension or worse improved to an elevated or normal range in 6 weeks. Mr. Williams’s data didn’t include a time frame, according to the documents.</p>\n<p>The Apple spokesman said that other companies analyze their hypertension data differently and that the data cited by Mr. Williams in the meeting was for an internal pilot, not a product.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Struggles in Push to Make Healthcare Its Greatest Legacy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Struggles in Push to Make Healthcare Its Greatest Legacy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 14:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/apple-struggles-in-push-to-make-healthcare-greatest-legacy-11623832200?mod=hp_lead_pos3><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tech giant has envisioned hiring doctors to offer primary care, now focused on Watch\nUnder the leadership of CEO Tim Cook, Apple has increased its research-and-development budget eightfold to $20 ...</p>\n\n<a href=\"https://www.wsj.com/articles/apple-struggles-in-push-to-make-healthcare-greatest-legacy-11623832200?mod=hp_lead_pos3\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.wsj.com/articles/apple-struggles-in-push-to-make-healthcare-greatest-legacy-11623832200?mod=hp_lead_pos3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139981231","content_text":"Tech giant has envisioned hiring doctors to offer primary care, now focused on Watch\nUnder the leadership of CEO Tim Cook, Apple has increased its research-and-development budget eightfold to $20 billion annually.\nApple Inc. Chief Executive Tim Cook has said the company’s greatest contribution to mankind will be in health. So far, some Apple initiatives aimed at broadly disrupting the healthcare sector have struggled to gain traction, according to people familiar with them and documents reviewed by The Wall Street Journal.\nApple has envisioned an audacious plan for healthcare, offering its own primary-care medical service with Apple-employed doctors at its own clinics, according to people familiar with the plan and documents. To test that and other bold healthcare ideas, it took over clinics that catered to its employees and built a team with scores of clinicians, engineers, product designers and others.\nToday those ambitions, which aren’t widely known, have largely stalled as Apple has shifted the focus of its health unit to something it knows well: Selling devices, specifically the Apple Watch, according to people familiar with its strategy.\nThe new primary-care service hasn’t gotten off the ground, people familiar with it say. A digital health app launched quietly this year has struggled to keep users engaged, say people familiar with the app and the documents seen by the Journal. Some employees have raised questions internally about the integrity of health data coming from the company’s clinics that has been used to support product development, according to people familiar with their concerns and the documents.\nAn Apple spokesman said data integrity is the foundation for all of the company’s innovations. He pointed to the accomplishments of its health team and said the company is still in the early innings of its work in healthcare, adding that new technology such as heart-rate notifications in products like the Apple Watch have improved users’ health. He said data gathered by Apple’s devices is enabling new research that has the potential to improve care.\n“Many of the assertions in this report are based on incomplete, outdated and inaccurate information,” the spokesman said.\nLooking for new markets where technology can improve efficiency and outcomes—and power sales growth—the tech sector has eyed healthcare as an untapped opportunity. Some of tech’s biggest efforts have failed, includingHaven,Amazon.com Inc.’s high-profile partnership with other companies that aimed to reduce healthcare costs. Today, Amazon has a new effort to sell prescriptions and a plan to launch virtual care across 50 states.\nUnder Mr. Cook’s leadership, Apple has increased its research-and-development budget eightfold to $20 billion annually, according to its public filings. And besides a smartwatch, the company has released wireless headphones as well as new services. It has also invested heavily in health, autonomous driving and augmented reality, all technically complex, high-stakes areas, meaning that game-changing offerings could be years away or never come.\nApple can study markets for years before coming up with its own offering, and it sometimes works extensively on new projects or technologies that it ultimately doesn’t bring to market.\nOne of its most ambitious healthcare ideas was a plan to offer primary-care medicine, conceived in 2016, according to documents and the people familiar with the plan. An Apple team spent months trying to figure out how the flood of health and wellness data collected from users of its smartwatch, first released in 2015, might be used to improve healthcare, the people said.\nApple Chief Operating Officer Jeff Williams, who oversees the health team, urged employees to think big. He said Apple should disrupt what he called the “363” and “break fix” model of care in the U.S., where patients may not see their doctors 363 days a year and only visit when something goes wrong, according to people familiar with his ideas.\nApple Chief Operating Officer Jeff Williams oversees its health unit.\nThe team decided one of the best ways to realize that vision was to provide a medical service of its own, said people familiar with the plan, linking data generated by Apple devices with virtual and in-person care provided by Apple doctors. Apple would offer primary care, but also continuous health monitoring as part of a subscription-based personalized health program, according to these people and the documents.\nIf Apple could prove that its combination of device sensors, software and services could improve people’s health and lower costs, the company could franchise the model to health systems and even other countries, according to the documents.\nTo start, Apple chose to test the service out on its own employees. Apple took over employee health clinics near its headquarters that were being run by a startup and turned them into test beds for new health services, say people familiar with the changes. In 2017 it hired Dr. Sumbul Desai from Stanford University to run the effort, which was given the code name Casper, said the people familiar with the plan.\nThe effort continues today, but Apple has struggled to move Casper past a preliminary stage, say people familiar with its operations.\nDr. Desai’s unit in particular has seen multiple departures by employees who say its culture discourages critical feedback, which is potentially problematic for a unit focused on products and services related to personal health, according to people familiar with its culture and the documents. Some employees expressed concerns that internal data about the clinics’ performance, data that was recently used to support the rollout of a new digital health app, has been inaccurate or compiled haphazardly, according to the documents and people familiar with the data.\nThose issues have been repeatedly voiced to Messrs. Cook and Williams, according to the documents and people familiar with the issues.\nApple’s spokesman said such criticisms are inaccurate.\nDr. Sumbul Desai runs a team that oversees clinics, handles relations with regulators and spearheads research collaborations.\nEmployees concerned about the culture pointed to a 2019 meeting during which a midlevel manager raised questions about data, according to people familiar with the meeting and the documents. Dr. Desai responded angrily, leading some present to conclude that critical questions were unwelcome, according to the people and the documents. The manager left Apple weeks later and the episode contributed to her departure, documents show.\nApple’s spokesman said Dr. Desai spoke to the importance of data integrity in the meeting. “This matter was investigated thoroughly and the allegations could not be substantiated,” the spokesman said. Apple declined to comment on the circumstances of the employee’s departure.\nThe spokesman said the company is proud of Dr. Desai’s work and that she has been instrumental in much of its healthcare work.\nMr. Williams and Dr. Desai didn’t respond to a request for comment and Apple declined to make them available.\nIn addition to overseeing the clinics, known as AC Wellness, Dr. Desai’s team handles relations with regulators, spearheads research collaborations and provides clinical expertise on other health products at Apple.\nA recent initiative for Dr. Desai’s team, a digital health app called HealthHabit that is being tested on California-based Apple employees, has struggled with low engagement since the app’s launch roughly six months ago, according to documents and people familiar with the app.\nHealthHabit offers to connect people with clinicians via chat and encourages them to set health challenges such as “I will exercise more this week.” Those with a history of hypertension can be connected to health coaches who can send them a blood-pressure monitor and scale and advise them on healthier habits.\nHalf the people who had downloaded it as of May hadn’t enrolled and engagement among many who have enrolled has been low, according to the documents and people familiar with the app.\nData supporting the app’s hypertension program has caused new concerns among employees about the integrity of internal data and analysis, some of the people said.\nDuring a presentation for all Apple health employees in March, Mr. Williams praised the clinics’ results in treating hypertension and pointed to them as evidence supporting the HealthHabit app’s potential, according to people who saw the presentation. He suggested that the company may have wider ambitions for the app if it is successful, they said.\nIn the meeting, Mr. Williams showed data indicating that 91% of patients in Apple’s clinics with more severe stage-two hypertension improved to healthier stages or normal, according to documents reviewed by the Journal, a figure that some employees feared could overstate the clinics’ success, according to people who attended the meeting and documents.\nRival companies offering hypertension apps have disclosed lower rates of success. Hello Heart Inc. reported 23% of stage 2 patients saw a significant improvement in blood pressure at 6 weeks. Livongo claimed one-third of patients with stage one hypertension or worse improved to an elevated or normal range in 6 weeks. Mr. Williams’s data didn’t include a time frame, according to the documents.\nThe Apple spokesman said that other companies analyze their hypertension data differently and that the data cited by Mr. Williams in the meeting was for an internal pilot, not a product.","news_type":1},"isVote":1,"tweetType":1,"viewCount":214,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163364552,"gmtCreate":1623860017076,"gmtModify":1703821810832,"author":{"id":"3572681899540620","authorId":"3572681899540620","name":"shashank5208","avatar":"https://static.tigerbbs.com/c8716a179dd0c77f629ba1cefc16da21","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572681899540620","idStr":"3572681899540620"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/163364552","repostId":"1109608534","repostType":4,"repost":{"id":"1109608534","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623852639,"share":"https://ttm.financial/m/news/1109608534?lang=&edition=fundamental","pubTime":"2021-06-16 22:10","market":"us","language":"en","title":"Cruise Stocks Gain As Wolfe Upgrades On Improving Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=1109608534","media":"Tiger Newspress","summary":"Shares of the largest cruise operators, namely Royal Caribbean, Norwegian Cruise Line and Carnival, ","content":"<p>Shares of the largest cruise operators, namely Royal Caribbean, Norwegian Cruise Line&nbsp;and Carnival, were up in&nbsp;moring&nbsp;trading on an upgrade by Wolfe Research.</p>\n<p>Early signs of customer demand for the return of vacations at sea should make investors more bullish on cruise stocks, according to Wolfe Research.</p>\n<p>The cruise industry was one of the hardest hit by the pandemic, with voyages being stopped around the world, but with widespread vaccinations in the U.S., the major companies have plans toresume American operations over the summer.</p>\n<p>Analyst Greg Badishkanian upgraded&nbsp;Carnival,Royal Caribbean&nbsp;and&nbsp;Norwegian Cruise Line Holdingsto outperform from peer perform, saying in a note to clients on Wednesday that early indications pointed to a strong restart for the industry.</p>\n<p>“Our checks suggest improving booking / pricing trends out of North America over the past month, with stronger trends over the past week. While there is some lingering uncertainty surrounding the U.S. restart (CDC / Florida, etc.), we view those unknowns as largely transitory when viewed against the broader reopening backdrop,” the note said.</p>\n<p>Bookings and demand are running ahead of pre-pandemic levels, according to Wolfe.</p>\n<p>“Cumulative 2022 bookings are now up approx. +10% to +15% versus 2019 levels with signs of improving 1Q demand (especially in January). Pricing is up in the +15% to 25% range vs. 2019 before factoring in [future cruise credits],” the note said.</p>\n<p>Wolfe has price targets of $32 per share for Carnival, $96 for Royal Caribbean and $36 for Norwegian. Those represent upside of roughly 12%, 8% and 17%, respectively.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cruise Stocks Gain As Wolfe Upgrades On Improving Demand</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCruise Stocks Gain As Wolfe Upgrades On Improving Demand\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-16 22:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of the largest cruise operators, namely Royal Caribbean, Norwegian Cruise Line&nbsp;and Carnival, were up in&nbsp;moring&nbsp;trading on an upgrade by Wolfe Research.</p>\n<p>Early signs of customer demand for the return of vacations at sea should make investors more bullish on cruise stocks, according to Wolfe Research.</p>\n<p>The cruise industry was one of the hardest hit by the pandemic, with voyages being stopped around the world, but with widespread vaccinations in the U.S., the major companies have plans toresume American operations over the summer.</p>\n<p>Analyst Greg Badishkanian upgraded&nbsp;Carnival,Royal Caribbean&nbsp;and&nbsp;Norwegian Cruise Line Holdingsto outperform from peer perform, saying in a note to clients on Wednesday that early indications pointed to a strong restart for the industry.</p>\n<p>“Our checks suggest improving booking / pricing trends out of North America over the past month, with stronger trends over the past week. While there is some lingering uncertainty surrounding the U.S. restart (CDC / Florida, etc.), we view those unknowns as largely transitory when viewed against the broader reopening backdrop,” the note said.</p>\n<p>Bookings and demand are running ahead of pre-pandemic levels, according to Wolfe.</p>\n<p>“Cumulative 2022 bookings are now up approx. +10% to +15% versus 2019 levels with signs of improving 1Q demand (especially in January). Pricing is up in the +15% to 25% range vs. 2019 before factoring in [future cruise credits],” the note said.</p>\n<p>Wolfe has price targets of $32 per share for Carnival, $96 for Royal Caribbean and $36 for Norwegian. Those represent upside of roughly 12%, 8% and 17%, respectively.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RCL":"皇家加勒比邮轮","CCL":"嘉年华邮轮","NCLH":"挪威邮轮"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1109608534","content_text":"Shares of the largest cruise operators, namely Royal Caribbean, Norwegian Cruise Line and Carnival, were up in moring trading on an upgrade by Wolfe Research.\nEarly signs of customer demand for the return of vacations at sea should make investors more bullish on cruise stocks, according to Wolfe Research.\nThe cruise industry was one of the hardest hit by the pandemic, with voyages being stopped around the world, but with widespread vaccinations in the U.S., the major companies have plans toresume American operations over the summer.\nAnalyst Greg Badishkanian upgraded Carnival,Royal Caribbean and Norwegian Cruise Line Holdingsto outperform from peer perform, saying in a note to clients on Wednesday that early indications pointed to a strong restart for the industry.\n“Our checks suggest improving booking / pricing trends out of North America over the past month, with stronger trends over the past week. While there is some lingering uncertainty surrounding the U.S. restart (CDC / Florida, etc.), we view those unknowns as largely transitory when viewed against the broader reopening backdrop,” the note said.\nBookings and demand are running ahead of pre-pandemic levels, according to Wolfe.\n“Cumulative 2022 bookings are now up approx. +10% to +15% versus 2019 levels with signs of improving 1Q demand (especially in January). Pricing is up in the +15% to 25% range vs. 2019 before factoring in [future cruise credits],” the note said.\nWolfe has price targets of $32 per share for Carnival, $96 for Royal Caribbean and $36 for Norwegian. Those represent upside of roughly 12%, 8% and 17%, respectively.","news_type":1},"isVote":1,"tweetType":1,"viewCount":81,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}